Risk models constructed based on CAF-related genes, CDR2L, SPRED1, PFKP, ENG, KLF2, FSCN1 and VCAN were able to predict their association with prognosis, chemotherapy and immunotherapy response of HCC patients. The gene discussed is KLF2; the disease is hepatocellular carcinoma.